Satoshi Minoshima named president of SNMMI

A new group of officers has been selected at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 annual meeting, including president Satoshi Minoshima, MD, PhD, professor and chair of the department of radiology and imaging sciences at the University of Utah in Salt Lake City.

“As SNMMI president, I will vigorously pursue the second stage of SNMMI’s Value Initiative—Value Initiative 2.0,” Minoshima said in a statement. “We will advance our strong research and development efforts in theranostics, new biomarkers and instrumentation. We will support current and future value-focused practice of nuclear medicine and molecular imaging through creation of guidelines and care pathways. We will focus on advocacy to advance reimbursement strategies for our high-value patient care. We will strategize our future training pathways and promote our members’ leadership in the imaging and healthcare fields. We will continue our prolific outreach efforts to patients, referral communities and other stakeholders. And, we will promote diversity in workforce and leadership,” he said. 

In addition to Minoshima, SNMMI elected other officers during its annual meeting, including:

  • President-elect: Vasken Dilsizian, MD, professor of radiology and medicine at the University of Maryland School of Medicine and chief of the Division of Nuclear Medicine at the University of Maryland Medical Center in Baltimore.
  • Vice president-elect: Alan Packard, PhD, associate professor of radiology at Harvard Medical School, director of radiopharmaceutical research and a senior research associate in nuclear medicine at Boston Children's Hospital.
  • President of the Technologist Section (SNMMI-TS): Norman E. Bolus, program director and assistant professor at the University of Alabama at Birmingham (UAB) School of Health Professions.
""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.